Results 191 to 200 of about 89,996 (262)

Severity of MASH activity by iron-corrected MRI predicts insulin resistance and cardiometabolic risk in type 2 diabetes.

J Clin Endocrinol Metab
Ortiz Rocha A, Kalavalapalli S, Godinez Leiva E, Barb D, Bril F, Marangi SA, Thomaides-Brears HB, Rosenberg JT, Cuervo-Pardo N, Lomonaco R, Valdez Saenz E, Sharma A, Cusi K.   +12 more
europepmc   +1 more source

Cell type-specific paradox of autophagy and senescence in MASH: implications for precision hepatology. [PDF]

Front Cell Dev Biol
Bahar ME, Kim DR.
europepmc   +1 more source

CD36‐mediated lipid rewiring in the metabolic adaptation of tumour ecosystems

The FEBS Journal, EarlyView.
Nutrient deprivation drives a lipid‐centric shift in tumour metabolic symbiosis and signalling network. CD36 functions as a bidirectional bridge, transferring fatty acids from stromal donors (adipocytes, CAFs) to the ecosystem tumour‐ and microenvironment‐dependently.
Anna Sebestyén, Viktória Varga, Fatime Szalai, Risa Miyaura, Nóra Förhécz, Bálint Csikós, Rebeka Gelencsér, Zsófia Gábriel, Timea Komlódi, Katalin Dezső, Ildikó Krencz, Dorottya Moldvai   +11 more
wiley   +1 more source

Correction: Pedersen et al. A Guinea Pig Model of Pediatric Metabolic Dysfunction-Associated Steatohepatitis: Poor Vitamin C Status May Advance Disease. <i>Nutrients</i> 2025, <i>17</i>, 291. [PDF]

Nutrients
Pedersen K, Poojari A, Colberg SF, Mechernsee SM, Iversen JF, Barrès R, Lykkesfeldt J, Tveden-Nyborg P.   +7 more
europepmc   +1 more source

Potential Role of Liver Transplantation for Child–Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan—A Retrospective Single‐Center Study

Hepatology Research, EarlyView.
Among patients with CP‐A HCC initially within the Japan criteria, some lose oncological eligibility for LT before hepatic decompensation. Further studies are needed to identify baseline factors associated with poor outcomes and to evaluate their relevance to future LT candidacy.
Akihiro Seki, Tomoyoshi Chiba, Shintaro Yagi, Rika Horii, Noboru Takata, Hiroki Nomura, Masaki Miyazawa, Tomoyuki Hayashi, Takeshi Terashima, Shinichi Nakanuma, Mitsuyoshi Okazaki, Satoshi Takada, Tatsuya Yamashita, Masao Honda, Hajime Takatori, Tetsuro Shimakami, Taro Yamashita   +16 more
wiley   +1 more source

Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis. [PDF]

Nat Genet
Boesch M, Anak S, El Abyad D, Ostyn T, Antoranz A, My Van T, Newhouse D, Myers C, Van Melkebeke L, Palmer J, Saffarzadeh N, Chui JS, Feio-Azevedo R, Smets L, Shankar G, Dubroja Lakić N, Calvo PL, Voet T, Clark J, Cockell S, Lannoo M, Deleus E, Jaekers J, Topal H, Topal B, Schneider KM, Vacca M, Allison M, Ekstedt M, Boursier J, Bugianesi E, Ratziu V, De Smet F, Boeckx B, Daly AK, Schattenberg JM, Verbeek J, Bosisio F, Lambrechts D, Roskams T, Schneider CV, Francque S, Korf H, Härtlova A, Tiniakos D, Anstee QM, van der Merwe S, Govaere O.   +47 more
europepmc   +1 more source

Indoleamine 2,3‐Dioxygenase 1 as an Adjunctive Histopathological Marker of Cholangitis Activity in Primary Biliary Cholangitis

Hepatology Research, EarlyView.
IDO‐1 immunostaining identifies primary biliary cholangitis even in morphologically subtle bile duct lesions. IDO‐1 expression reflects cholangitis activity and is suppressed by ursodeoxycholic acid treatment, indicating its value as a dynamic diagnostic adjunct rather than a static marker of chronic damage.
Kaori Yoshimura, Shinji Shimoda, Ryoka Masuda, Tram Nguyen Thi, Rui Yang, Quynh Nguyen Thi, Dong Le Thanh, Yuko Tamano, Yasunori Sato, Taro Yamashita, Kenichi Harada   +10 more
wiley   +1 more source

Correction to: Phytic acid-based nanomedicine against mTOR represses lipogenesis and immune response for metabolic dysfunction-associated steatohepatitis therapy. [PDF]

Life Metab
europepmc   +1 more source

Morphological characterization of a novel model of steatohepatitis in the <i>FAH</i>^<i>-/-</i> pig. [PDF]

Vet Pathol
Wilken SN, Felgendreff P, Minshew A, Ahmadzada B, Hosseiniasl SM, Kazeminia S, Ezenekwe K, Patil A, Park BU, Sultan A, Smith L, Cisneros Correa J, Hussein K, Malhi H, Moreira RK, Nyberg SL.   +15 more
europepmc   +1 more source

UltRaSoUnd‐guided evaLuAtion of metabolic health in a cohort of midlife women with HIV: The URSULA study

HIV Medicine, EarlyView.
Abstract Objectives We aimed to determine the prevalence of metabolic disorders, liver steatosis and metabolic dysfunction‐associated steatotic liver disease (MASLD) in a cohort of middle‐aged women with HIV (WoWH) and to explore associations between liver steatosis, visceral fat depots and carotid atherosclerosis.
Mariacristina Poliseno, Davide Capruzzi, Antonio Cianciaruso, Nicola Colavito, Felicia Dalitto, Vincenzo Giliberti, Vittoria Lobalsamo, Giuliana Metrangolo, Marica Noviello, Alessandra Vigna, Maurizio Zarcone, Francesco Di Gennaro, Vincenzo Ostilio Palmieri, Annalisa Saracino   +13 more
wiley   +1 more source